A phenotype-stratified approach should prioritise weight control and compression as core interventions, with targeted nutraceuticals considered according to dominant clinical goals: symptom relief, quality of life, oedema control, or ulcer healing.
F. Fogacci, Valentina Di Micoli, A. Avagimyan et al.· Clinical Nutrition· 0 citations
While current evidence supports its association with incident CVD, atherosclerotic burden, and adverse outcomes, further prospective, multiethnic studies are needed to define optimal thresholds, clarify its role alongside existing risk models, and determine whether TyG-guided strategies can improve clinical outcomes.
M. Cherska, Khrystyna Kukharchuk, A. Ceasovschih et al.· Lipids in Health and Disease· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.